Lachlan Brown
Stock Analyst at Rothschild & Co
(1.43)
# 3,420
Out of 5,182 analysts
14
Total ratings
36.36%
Success rate
-3.2%
Average return
Main Sectors:
Stocks Rated by Lachlan Brown
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SPSC SPS Commerce | Downgrades: Neutral | $100 → $60 | $55.44 | +8.23% | 2 | Apr 16, 2026 | |
| DSGX The Descartes Systems Group | Upgrades: Buy | $100 → $90 | $70.94 | +26.88% | 2 | Apr 16, 2026 | |
| EPRX Eupraxia Pharmaceuticals | Initiates: Outperform | n/a | $7.16 | - | 1 | Mar 23, 2026 | |
| VRDN Viridian Therapeutics | Initiates: Outperform | n/a | $13.41 | - | 1 | Dec 3, 2025 | |
| MANH Manhattan Associates | Downgrades: Neutral | $270 → $200 | $141.09 | +41.75% | 2 | Jun 10, 2025 | |
| HROW Harrow | Initiates: Outperform | n/a | $40.52 | - | 1 | Jun 10, 2025 | |
| KLRS Kalaris Therapeutics | Initiates: Outperform | n/a | $5.89 | - | 1 | Apr 8, 2025 | |
| OCUL Ocular Therapeutix | Initiates: Outperform | n/a | $9.53 | - | 1 | Apr 8, 2025 | |
| SNPS Synopsys | Initiates: Buy | $600 | $482.93 | +24.24% | 1 | Jan 13, 2025 | |
| CDNS Cadence Design Systems | Initiates: Buy | $350 | $329.58 | +6.20% | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $40.95 | - | 1 | Oct 16, 2024 |
SPS Commerce
Apr 16, 2026
Downgrades: Neutral
Price Target: $100 → $60
Current: $55.44
Upside: +8.23%
The Descartes Systems Group
Apr 16, 2026
Upgrades: Buy
Price Target: $100 → $90
Current: $70.94
Upside: +26.88%
Eupraxia Pharmaceuticals
Mar 23, 2026
Initiates: Outperform
Price Target: n/a
Current: $7.16
Upside: -
Viridian Therapeutics
Dec 3, 2025
Initiates: Outperform
Price Target: n/a
Current: $13.41
Upside: -
Manhattan Associates
Jun 10, 2025
Downgrades: Neutral
Price Target: $270 → $200
Current: $141.09
Upside: +41.75%
Harrow
Jun 10, 2025
Initiates: Outperform
Price Target: n/a
Current: $40.52
Upside: -
Kalaris Therapeutics
Apr 8, 2025
Initiates: Outperform
Price Target: n/a
Current: $5.89
Upside: -
Ocular Therapeutix
Apr 8, 2025
Initiates: Outperform
Price Target: n/a
Current: $9.53
Upside: -
Synopsys
Jan 13, 2025
Initiates: Buy
Price Target: $600
Current: $482.93
Upside: +24.24%
Cadence Design Systems
Jan 13, 2025
Initiates: Buy
Price Target: $350
Current: $329.58
Upside: +6.20%
Oct 16, 2024
Initiates: Outperform
Price Target: n/a
Current: $40.95
Upside: -